Biotech

Magnifying glass focusing on number 2026 with target icon on yellow background

Biotech

Despite headwinds, biotech industry charges forward behind M&A

Biotech’s effervescent activity has allowed it to overcome headwinds and sustain momentum, as the volume and value of M&A deals continue to increase.

Kevin Dunleavy Jun 9, 2026 12:41pm

rollercoaster ride theme park scary crazy

Parabilis ups planned IPO haul to record-setting $637M

Jun 9, 2026 10:22am

How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

AlzeCure

Lilly licenses AlzeCure Alzheimer’s asset for $1B biobucks

Jun 9, 2026 10:16am

Managing complexity across biopharma modalities

Managing complexity across biopharma modalities

Brought to you by SK Pharmteco

ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2

Jun 9, 2026 9:48am